Pepgen announces upcoming presentations at the 28th annual congress of the world muscle society and the world congress of neurology

Boston, sept. 27, 2023 (globe newswire) -- pepgen inc. (nasdaq: pepg), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today announced that it will be presenting at the 28th annual congress of the world muscle society, being held october 3-7 in charleston, south carolina. details of the presentations can be found below:
PEPG Ratings Summary
PEPG Quant Ranking